|
US2014350097A1
|
|
Treatment of hypotension associated with hemodialysis
|
|
WO03099784A1
|
|
Method for preparation of pharmaceutical-grade disulfide of dithiocarbamates
|
|
US2003181495A1
|
|
Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
|
|
US2004077691A1
|
|
Hydroxamate derivatives of non-steroidal anti-inflammatory drugs
|
|
US6620813B1
|
|
Hydroxamate derivatives of non-steroidal anti-inflammatory drugs
|
|
US2003087840A1
|
|
Conjugates of dithiocarbamates with pharmacologically active agents and uses therefor
|
|
US2003022923A1
|
|
Methods for treatment of sickle cell anemia
|
|
US2002151540A1
|
|
Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
|
|
US6555563B1
|
|
Heteroaryl substituted amidinyl and imidazolyl compounds and methods employing same for the treatment of inflammation
|
|
AU7503601A
|
|
Protected forms of a combination of pharmacologically active agents and uses therefor
|
|
US6429223B1
|
|
Modified forms of pharmacologically active agents and uses therefor
|
|
US6355666B1
|
|
Protected forms of pharmacologically active agents and uses therefor
|
|
US6306842B1
|
|
Protected forms of a combination of pharmacologically active agents and uses therefor
|
|
US6710086B1
|
|
Protected forms of pharmacologically active agents and uses therefor
|
|
US6274627B1
|
|
Conjugates of dithiocarbamate disulfides with pharmacologically active agents and uses therefor
|
|
US6251927B1
|
|
Methods for treatment of sickle cell anemia
|
|
US6124349A
|
|
Method for preparation of pharmaceutical-grade dithiocarbamate
|
|
AU2662899A
|
|
Methods for the controlled delivery of carbon disulfide for the treatment of inflammatory conditions
|
|
AU2662799A
|
|
Modified pharmacologically active agents and improved therapeutic methods employing same
|
|
US6265420B1
|
|
Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide
|
